Ensign Peak Advisors, Inc Rocket Pharmaceuticals, Inc. Transaction History

Ensign Peak Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $5,937 - $8,836	480 Added 6.21%	8,210 $131,000
Q4 2021 Feb 11, 2022	BUY	$21.52 - $36.02 $166,349 - $278,434	7,730 New	7,730 $169,000
Q2 2021 Aug 13, 2021	SELL	$39.41 - $47.25 $1.26 Million - $1.51 Million	-32,021 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$43.34 - $65.91 $375,627 - $571,241	8,667 Added 37.11%	32,021 $1.42 Million
Q4 2020 Feb 12, 2021	BUY	$23.3 - $59.57 $123,490 - $315,721	5,300 Added 29.36%	23,354 $1.28 Million
Q3 2020 Nov 12, 2020	BUY	$20.5 - $28.59 $370,107 - $516,163	18,054 New	18,054 $413,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $987M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.